Biotech
Guardant Health
Guardant Health raises $360M Series E at $2.15B valuation
$360M
Total Raised
Series E
Latest Round
2012
Founded
1000+
Employees
Redwood City, CA
1 min read
Quick Facts
Valuation
$2.15B
Latest Round Size
$360M
Latest Round Date
May 2018
Guardant Health: Series E Funding Round
Guardant Health has successfully raised $360M in Series E funding, reaching a valuation of $2.15B.
Company Overview
Blood-based cancer detection and monitoring
Funding Details
The Series E round was led by SoftBank Vision Fund, with participation from OrbiMed.
Company Information
- Headquarters: Redwood City, CA
- Founded: 2012
- Employees: 1000+
- Category: Biotech
Investment
Guardant Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- SoftBank Vision Fund: Verified investor in Series E
- OrbiMed: Verified investor in Series E
Key Investors
SoftBank Vision Fund
Lead Investor
Verified investor in Series E
OrbiMed
Investor
Verified investor in Series E
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min readβ’$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min readβ’$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min readβ’$250M